Citadel Advisors’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-520,560
| Closed | -$12.5M | – | 6835 |
|
|
2023
Q1 | $12.5M | Buy |
520,560
+477,796
| +1,117% | +$11.5M | ﹤0.01% | 1159 |
|
|
2022
Q4 | $452K | Sell |
42,764
-191,162
| -82% | -$2.02M | ﹤0.01% | 3962 |
|
|
2022
Q3 | $1.05M | Buy |
233,926
+87,503
| +60% | +$394K | ﹤0.01% | 3362 |
|
|
2022
Q2 | $586K | Buy |
146,423
+98,892
| +208% | +$396K | ﹤0.01% | 3976 |
|
|
2022
Q1 | $348K | Sell |
47,531
-115,805
| -71% | -$848K | ﹤0.01% | 4807 |
|
|
2021
Q4 | $918K | Buy |
163,336
+22,121
| +16% | +$124K | ﹤0.01% | 3932 |
|
|
2021
Q3 | $904K | Sell |
141,215
-32,499
| -19% | -$208K | ﹤0.01% | 3897 |
|
|
2021
Q2 | $1.46M | Buy |
173,714
+21,807
| +14% | +$184K | ﹤0.01% | 3583 |
|
|
2021
Q1 | $1.59M | Buy |
151,907
+121,012
| +392% | +$1.27M | ﹤0.01% | 3431 |
|
|
2020
Q4 | $523K | Sell |
30,895
-31,179
| -50% | -$528K | ﹤0.01% | 3821 |
|
|
2020
Q3 | $796K | Buy |
62,074
+29,645
| +91% | +$380K | ﹤0.01% | 3109 |
|
|
2020
Q2 | $458K | Buy |
+32,429
| New | +$458K | ﹤0.01% | 3526 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5469 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5280 |
|
|
2019
Q2 | – | Sell |
-16,864
| Closed | -$39K | – | 5247 |
|
|
2019
Q1 | $39K | Buy |
+16,864
| New | +$39K | ﹤0.01% | 4295 |
|